Genzyme to pay $175 million for Allston plant woes - MarketWatch
Genzyme to pay $175 million for Allston plant woesMarketWatch... company disgorge $175 million of its past profits as a penalty for chronic quality-control problems at a key manufacturing facility in Allston, Mass. ...Genzyme expects to pay $175m consent decreeBoston GlobeGenzyme Loses $115M In Q1 On FDA FineWorcester Business JournalDecree spells out $175M fine, new penalties for GenzymeFierceBiotechEasy Bourse�-Reutersall 10 news articles��
Blog Content
No comments:
Post a Comment